Little Green Pharma has become the first Australian company to export a locally-grown medicinal cannabis product to Germany.
The company, which is 40% owned by Elixxer, has now entered
the German market by supplying samples of its commercial products to German
cannabis distribution and wholesaler Cansativa for product testing.
Little Green Pharma managing director, Fleta Solomon, said: “Being Australia’s first local producer of medicinal cannabis to have its products reach European soil is a major milestone in the company’s short history.
“This partnership with Cansativa also highlights that our
goal of bringing high-quality, cost-competitive Australian-produced medicinal
cannabis to patients around the world has become a reality.
“We are thrilled to be working with a company of Cansativa’s
standing, with this partnership just the beginning in LGP achieving its global
Germany is one of the fastest growing markets for medicinal cannabis in Europe since its legalisation in 2017.
However, domestic cultivation has lagged due to delays in the tendering process which has resulted in product having to be imported in order to meet the increased demand, a press release states.
Cansativa co-founder and co-managing director Benedikt Sons
added: “This partnership underlines Cansativa’s aspiration to provide security
of supply in the German market and is an important step for commercialising
Australian cannabis in Europe.
“This agreement is an important step in ensuring security of supply for patients in Germany”
“LGP will help us to tackle the growing supply problems in
the German market and secure the amount of deliveries necessary to meet the
increasing demands by patients. This agreement is an important step in ensuring
security of supply for patients in Germany.
“Cansativa has aggregated a lot of know-how over the last
year regarding process reliability, dealing with authorities, market structure,
competition, and the necessary legal expertise.
“With the Australian import, we underscore our ambition to
provide security of supply through global sourcing.”